Search our Database of Scientific Publications and Authors

I’m looking for a

    Details and Download Full Text PDF:
    The three CYBA variants (rs4673, rs1049254 and rs1049255) are benign: new evidence from a patient with CGD.

    • Authors:
    • Jinqiao Sun
      Children's Hospital of Fudan University
      China
      Min Wen
      Guangdong Medical College
      China
      Ying Wang
      CAS Key Laboratory of Functional Materials and Devices for Special Environments
      Hong Kong
      Danru Liu
      Children's Hospital of Fudan University
      China
      Wenjing Ying
      Children's Hospital of Fudan University
      China
      Xiaochuan Wang
      Fudan University
      China
    BMC Med Genet 2017 11 13;18(1):127. Epub 2017 Nov 13.
    Department of Clinical Immunology, Children's Hospital of Fudan University, 399 Wanyuan Road, Shanghai, 201102, China.
    Background: Chronic granulomatous disease (CGD) is an inherited immunodeficiency disease caused by the defect of NADPH oxidase. Mutations in CYBB or CYBA gene may result in membrane subunits, gp91phox or p22phox, expression failure respectively and NADPH oxidase deficiency. Previous study showed that three variants, c.214 T > C (rs4673), c.521 T > C (rs1049254) and c.24G > A (rs1049255), in CYBA gene form a haplotype, which are associated with decreased reactive oxygen species generation. The study aims to confirm the three above mentioned variants are benign and report a novel mutation in CYBB gene.

    Methods: A patient with CGD and his family members were enrolled in the study. NADPH oxidase activity and gp91phox protein expression of neutrophils were analyzed by flow cytometry. Direct sequencing was used to detect CYBB and CYBA gene mutations.

    Results: The patient was diagnosed with CGD according to clinical and immune phenotype. The case has a novel homozygous mutation in CYBB gene and the above mentioned three variants in CYBA gene. The mutation in CYBB gene was confirmed to be pathogenic, and the three variants in CYBA gene to be benign.

    Conclusions: The study not only reported a novel mutation in CYBB, which results in CGD, but also confirmed the above mentioned three variants in CYBA are benign.
    PDF Download - Full Text Link
    ( Please be advised that this article is hosted on an external website not affiliated with PubFacts.com)
    Source Status
    http://dx.doi.org/10.1186/s12881-017-0492-6DOI ListingPossible
    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683331PMCFound

    Similar Publications

    Genetic and mutational heterogeneity of autosomal recessive chronic granulomatous disease in Tunisia.
    J Hum Genet 2006 26;51(10):887-95. Epub 2006 Aug 26.
    Molecular Investigation of Genetic Orphan Diseases Research Unit, MIGOD, Institut Pasteur de Tunis, BP 74, 13 Place Pasteur 1002, Tunis, Tunisia.
    NADPH oxidase, a multi-subunit protein consisting of cytosolic components and the membrane-bound heterodimer, plays an instrumental role in host defence mechanisms of phagocytes. Genetic deficiency of the enzymatic complex results in an inherited disorder, chronic granulomatous disease (CGD), which is characterized by an impaired phagocyte microbicidal activity. X-Linked (XL) CGD results from a mutation in the CYBB gene encoding the gp91phox subunit, while autosomal recessive (AR) CGD is associated with mutations in one of the NCF1, NCF2 and CYBA genes that encode the p47phox, p67phox and p22phox subunits, respectively. Read More
    A novel missense mutation in the NADPH binding domain of CYBB abolishes the NADPH oxidase activity in a male patient with increased susceptibility to infections.
    Microb Pathog 2016 Nov 23;100:163-169. Epub 2016 Sep 23.
    The Department of Chemistry, University of Oxford, Oxford, United Kingdom.
    Chronic granulomatous disease (CGD) is a primary immunodeficiency caused by mutations in the five structural genes (CYBB, CYBA, NCF1, NCF2, and NCF4) that typically results in a decrease in function or inability to generate a respiratory burst, leading to defective killing of pathogens, including fungi and intracellular bacteria. Mutations in CYBB, encoding the gp91phox (also known as NOX2) result in X-linked CGD account for approximately 65% of CGD cases. Here, we aimed the characterization of a novel missense mutation c. Read More
    Molecular diagnosis of X-linked chronic granulomatous disease in Iran.
    Int J Hematol 2008 May;87(4):398-404
    Laboratory of Molecular Biology Immunology, Asthma and Allergy Research Institute, Medical sciences of Tehran University, Tehran, Iran.
    Chronic granulomatous disease (CGD) is an inherited disorder of pathogen killing by phagocytic leukocytes caused by mutations in NADPH oxidase subunits. Patients with CGD have life-threatening bacterial and fungal infections. Children's Medical Center at Tehran University is the referral center for immunodeficiency in Iran. Read More
    A Founder Effect of c.257 + 2T > C Mutation in NCF2 Gene Underlies Severe Chronic Granulomatous Disease in Eleven Patients.
    J Clin Immunol 2016 Aug 25;36(6):547-54. Epub 2016 May 25.
    Laboratory of Transmission, Control and Immunobiology of Infections (LTCII), LR11IPT02, Institut Pasteur de Tunis, Pasteur, 1002, Tunis-Belvedere, Tunisia.
    Chronic granulomatous disease (CGD) is the prototypic functional neutrophil disorder caused by genetic defects in one of the five genes encoding the superoxide-generating nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase subunits of phagocytes. Mutations causing the most prevalent form of CGD in western populations are located in the X-linked-CYBB gene. The four remaining autosomal recessive (AR) forms collectively account for one-third of CGD cases. Read More